{"name":"United BioPharma","slug":"united-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"UB-421","genericName":"UB-421","slug":"ub-421","indication":"HIV-1 infection (in combination antiretroviral therapy)","status":"phase_3"}]}],"pipeline":[{"name":"UB-421","genericName":"UB-421","slug":"ub-421","phase":"phase_3","mechanism":"UB-421 is a monoclonal antibody that targets and blocks CD4 on T cells to modulate immune function in HIV infection.","indications":["HIV-1 infection (in combination antiretroviral therapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNRnRmY0JZb2pWRkxOTmRWT1liR0p4Smh0TzVhNDVFaHd0SGNoS0VVWVM2dW1fVkV3UzFJZUVNR3lUUDU0Q01fbW40XzlIQldVbkNmcVFLeWxDX1Rkb1dST1ljdTFZdDJOa3hOQnVPdDJqVlZaMFFmUnlTQ0RRVjFXcFhBVFRxQWMzWWxoam5YWjVSazg0SVZn?oc=5","date":"2026-01-14","type":"pipeline","source":"Coalition For A Prosperous America","summary":"The China Dependence Big Pharma Doesn’t Want Washington to See - Coalition For A Prosperous America","headline":"The China Dependence Big Pharma Doesn’t Want Washington to See","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSUt6TjhqalJoV0RyTGFjdVoyaUdFQ3VFbHlVNXBpQ2lPMXdmU2pXbGxSTWtmY0otM0dTZktkS3pXVXk2Y2RYTnAtOUJJTDlzRkFwOXlkaDNMTS1lYm4wMXNZbGpuYWhTUFZHUlF2clJHU2tLaVQ3WXFDQ1E5WFJBR2hiY3dPNUFQbURaZjNJOGlUU3lSTGZHUkxJOGtBaUJnTW9SZ3JtMXN2bUdMY3psLU15dzBMX2ZR?oc=5","date":"2026-01-07","type":"pipeline","source":"McKinsey & Company","summary":"The emerging epicenter: Asia’s role in biopharma’s future - McKinsey & Company","headline":"The emerging epicenter: Asia’s role in biopharma’s future - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQeXdJQkZVUGVzNGV1aWxOTTQwdnRYb21uZXY3c2o0eDdjMFVENmtmczJ3ZDA3R2QyaC1WTnNRamcwNERIMGl0emhab2tSdEtRc0xfQ1ZDV2lxWDAxS2hlYzIzekExbGItbVRpWFFURE14ME1jUGMxR3VsYzFjazdabFRuMURkSnBpSFpubVVuTEh4R1l0cy1NYVdGUk5QRnZ6Y2tSanc4TTFHLVVwclNCM01wNHU?oc=5","date":"2025-12-02","type":"pipeline","source":"Fierce Pharma","summary":"Pharmas have promised $370B in US investments amid 2025's onshoring boom: DPR - Fierce Pharma","headline":"Pharmas have promised $370B in US investments amid 2025's onshoring boom: DPR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNY1hWRDFvWmxGaU9TdnREVmxja0JnSk1TaVpVZDlJaXh3aWwwSmFWT0J4Zk1pcmlrOWlUYldWR0pGaXFKTkZPbExBSHdhN3kwTUsxTDhQbmFYNkQ3bm1fMlozS1VPcUpiWmpxcXZhSVBwNllHZHZ4ekdDZTR0UGUyN3ZGck92OURteTdnRS1oMlFWRjhmZzR2TnI4NFEtcVdnZXFqag?oc=5","date":"2025-12-01","type":"deal","source":"Fierce Pharma","summary":"In UK trade deal, Trump administration excludes drugs from tariffs and secures promise of more pharma investment - Fierce Pharma","headline":"In UK trade deal, Trump administration excludes drugs from tariffs and secures promise of more pharma investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE82OThUWWJnWGxucEFsTGxxUVRLMTh2akJCR1hxYVo2UDdIU0tEaFdHbEhCc1FwZkFtbGpmZm4yYmhRaGt1U0pNRGlYc3h2OW9aME95elJCdTRaSF9peENIR2VnRjhDb0x3MFNWcGJ30gFyQVVfeXFMUDlVbGwyejJxV3ZfNDFFdmZkRW0zNUFDMzMzUGYwdHpvTnE3Mk8tcnNUZTdwMnRUbUlQZHhHd0Qwa1JjQ3owN0xMQ1dnM1NtbzV5a0loYXZyeEtaZXZLcHQzZjJPMW9KcnRFcWlTV2p5emJR?oc=5","date":"2025-10-20","type":"deal","source":"koreabiomed.com","summary":"Korea United Pharm wins deal to supply MRI contrast in the Philippines - koreabiomed.com","headline":"Korea United Pharm wins deal to supply MRI contrast in the Philippines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9UelZJVi1YbENEd05yTmlNQXN2QmRsUlpBXzJWSTBYOW5Vek9BTWxxZ3FHc3JDRDBRVUZERUlpRzhtaTR3Wlk2U2Z5UFhyVXVpbkVqZmhqNGlHYkVFbGNKenhyYk1XcmdURTNtSjJIek16aExnWFZxQmtORy1YQQ?oc=5","date":"2025-10-11","type":"pipeline","source":"China Daily","summary":"Shanghai impresses global biotech, pharma markets with quality growth - China Daily","headline":"Shanghai impresses global biotech, pharma markets with quality growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNLUZBMW1ycFFMUExyYkNjQVlqNXVWeWRMbUhSOGdEdFF3azZWN0xrQ0ZteHpzYWVTQ2lyYkVEOUwxUVRnVVF5Wlkybm5jSVFCWWU5NENRVGJkekdNcDZLNGNVeG9mQnlJS0JvM3drQ3QtUHJlMzMwczVzX0M1TTJKVVEwNVY?oc=5","date":"2025-09-12","type":"pipeline","source":"The New York Times","summary":"U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China - The New York Times","headline":"U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaXEyTUd0TVd5WW9LTDNEWVBMbE1vRDBTSUpXdHcxdHFqczFDb2xOSkZ6akxVVEVnbDBzQjRRZ1dKUmc2UnRkckEtTjdhRllFaTNKU3d4UDdZWE9STzNMTUprY0l1bnRPQWxVbTgydklpWEp3VXV6YWRNb3hiRkw4RGx3MVQ0c0NvNnRGYkxxWkhOZ3Vpb2FnTHFEQWdreG90RVR1TXM3dHlGWGtaM1V2LUZqb1dSdTZsWXNr?oc=5","date":"2025-09-09","type":"pipeline","source":"CSIS | Center for Strategic and International Studies","summary":"How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today - CSIS | Center for Strategic and International Studies","headline":"How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today - CSIS | Center for Stra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNZnYwNG5JcE1jeVdJOUxRbS1UcHNHWlV3cDRoT0N3akVlUUkycnpnWmhhOC1KMDQ2Y3lpTzVjdVdSQmFtRGhzT01tc3dNU3lWRFZzN3NZQTl1YjB4aEstZHlfZ1NvLXd0UmdtLW5xdGo1dVVZYnNYUk1KZC02Z181N1ZyU29LdWs?oc=5","date":"2025-07-22","type":"pipeline","source":"The New York Times","summary":"AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat - The New York Times","headline":"AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQYTY2aHZQeDZrZHRYVzhSREVJMFlHM3c5clpKZkVaQzhlOGJTOTlNN3M4b2Q5YnViYjlsckxNd0xtbXdDbzJhWnIyY1Jua1NudllBOFUzWEU3OWp0amMzRVd2SGw1Qmg1aDgzWDdnUi1VMUxhcFFXVFhkMVR4dWNmeGppUHBkOUoxd3kybXFHRmloWWxBTTZtWnVUU3RyM0FsZk9PQ2pDTGlpM09yVE5zZ3NVYjhWdEVOUy1EOC1RTy1Sa2xtWTBTcHBZSQ?oc=5","date":"2025-07-09","type":"pipeline","source":"IQVIA","summary":"A Brave New World: Six Key Healthcare Industry Trends to Monitor in 2025 for Emerging Biopharma - IQVIA","headline":"A Brave New World: Six Key Healthcare Industry Trends to Monitor in 2025 for Emerging Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNREdKekFDOUhvQngxV1dyUXBuZzdhTklqeXJvYk13b01vY2FWUkZoa2w1YmNaZGFVNU05eE5iMlpRNGlZcmhNSGE1SlZQa01RSVFoaWdkWmI0V250NkZYbUpJd2hUT01OaEYxLUlKRUlRR2xPa1ZPM2dFcTBpSHRxRTJaRXdGd2ZMeG9YTG93YTRXRFBVZzNKazFuMUZSaXAwNW9GczNsT1k5WXNETUhBMjc5TU94WHZOc2hibQ?oc=5","date":"2025-03-28","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.? - Genetic Engineering and Biotechnology News","headline":"StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOajBXZEZXdXAyOWVVb0tqejNoM0hOWTN5cVJhX3ZMRHNwWFVnX1EzUEd4N0lLSm5fd0V0Z0F3Q0hkazFvWUdiNFhPTGdNcHN4TnlvcE5rMkE2a0NFWHh2VnZwWXU5amVoTjRNRTdNMEl2YmhGaVFXRTFCUy1OREg4dUNpOTM0RFhFVEhSMG10YmEwbUxyT0trUkFlRm94QUYxelBoZ0RqdlRvV3lvNXFrT1NOUHZGM0tteGRlTkd2Z0VCVXE3SXlXV1NBLUFjUQ?oc=5","date":"2023-07-26","type":"pipeline","source":"PhRMA","summary":"Biopharmaceutical manufacturing companies continue to expand their economic footprint across the United States - PhRMA","headline":"Biopharmaceutical manufacturing companies continue to expand their economic footprint across the United States","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}